RNU1-117P

Across TCGA pan-cancer cohorts, RNU1-117P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU1-117P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNU1-117P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-117P expression acts as an unfavorable survival marker.

PAAD, HNSC, and KIRC are the cancer types where RNU1-117P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.112	0.640	.004	36	view →
HNSC	OS	Tertile	IV	0.001	0.643	<.001	36	view →
KIRC	DFS	Tertile	IV	0.197	0.540	.006	30	view →
LIHC	OS	Tertile	II,III,IV	0.166	0.701	<.001	27	view →
CESC	DFS	Tertile	III,IV	0.221	0.634	.040	18	view →
LGG	OS	Tertile	All	0.165	0.468	.002	18	view →
LUAD	OS	Tertile	III,IV	0.083	0.680	<.001	18	view →
OV	DFS	Tertile	IV	0.267	0.484	.032	18	view →
BRCA	OS	Tertile	III,IV	0.670	0.840	.007	12	view →
GBM	OS	Tertile	All	0.121	0.415	.042	9	view →
SARC	DFS	Tertile	All	0.231	0.600	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU1-117P–PAAD (OS)

Open the PAAD breakdown →